Log In
Print
BCIQ
Print
Print this Print this
 

Vasomera (PB1046)

  Manage Alerts
Collapse Summary General Information
Company PhaseBio Pharmaceuticals Inc.
DescriptionVasoactive intestinal peptide receptor 2 (VPAC2) agonist
Molecular Target Vasoactive intestinal peptide receptor 2 (VPAC2)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I
Standard IndicationHypertension
Indication DetailsTreat essential hypertension
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today